Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mebeverine for Nocturnal Incontinence in Orthotopic Bladder Substitute
NCT04635566Completed
- Sponsor
- Mansoura University
- Start
- Mar 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of mebeverine in nocturnal enuresis (NE), sponsored by Mansoura University. Primary endpoint: Nocturnal continence rate at 3 months. Started Mar 2019; status: completed.
02
Drugs
mebeverine
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT04635566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04635566.